Pharma trends 2026 bring surging R&D costs, regulatory volatility, and tech disruptions, but AI innovations, decentralized trials, and promising clinical pipelines offer key opportunities for drug developers.

Attacks on oil facilities and missile bases in the U.S.-Israel war with Iran have raised…

From a 17-year development cycle to commercial launch, production has always been in Eztugo’s DNA.…

Severe cases of COVID-19 and influenza may cause more than just short-term illness. New research…

Recent research published in journals injury epidemiology provide evidence that military service or combat experience…

This week’s episode of “The Topline” takes a deep dive into the biopharmaceutical industry’s fourth…

In medieval Denmark, the place of burial often reflected a person’s wealth and status. Christians…

LAS VEGAS—As agent-based artificial intelligence becomes mainstream, a message released this week shows that federal…

Tracking smartphones over time reveals how deeply embedded they are in school life. Some teens…

The FDA has rejected Hyloris Pharmaceuticals’ antiviral drug valacyclovir, an oral suspension for infections caused…